BioVaxys Technology Corp. (CNSX: BIOV)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
BioVaxys Technology Corp. (CNSX: BIOV) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.27M and employs 3 people.
trading between 0.03 and 0.40.
Tweenvest scores BioVaxys Technology Corp. across four factors: quality 25/100, value 32/100. Its strongest factor is value.
BIOV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.27M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.22
- Dividend yield
- —
- Beta (5Y)
- 1.60
- 52-week high
- CA$0.40
- 52-week low
- CA$0.03
- Avg volume (3M)
- —
- Shares outstanding
- 44.09M
- Employees
- 3
- Next earnings
- —
About BioVaxys Technology Corp.
BioVaxys Technology Corp. is a clinical-stage biotechnology company specializing in the development of vaccine platforms designed to combat both viral infections and cancer. The company's pipeline includes BVX-0320, a single-strain vaccine for SARS-CoV-2, and BVX-0918A, an experimental haptenized tumor cell vaccine targeting ovarian cancer. Additionally, BioVaxys offers CoviDTH, an immunodiagnostic tool to detect immune system activity in SARS-CoV-2-exposed patients. Further initiatives encompass Papilocare, aimed at HPV-dependent cervical lesions, along with BVX-0918C for cervical cancer, the HPV viral vaccine BVX-0204, and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys has established strategic collaborations, such as a bioproduction agreement with WuXi Biologics Limited to manufacture SARS-CoV-2 s-proteins crucial for BVX-0320 and CoviDTH. It also holds a research partnership with The Ohio State University, Wexner School of Medicine, focusing on BVX-0320, and has engaged Bioanalytical Systems, Inc. for preclinical toxicology evaluations of its CoviDTH immunodiagnostic. The company is headquartered in Vancouver, Canada.
- ISIN
- CA09076M2004
- Listed since
- Nov 27, 2018
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Société des Industries Pharmaceutiques de Tunisie - S.A.BVMT: SIPHA | $2.38M | DT3.97 | -12.56% |
| Pharmesis International Ltd.SGX: BFK | $2.36M | S$0.10 | — |
| Ishita Drugs and Industries LimitedBSE: 524400 | $2.35M | Rs76.00 | -0.26% |
| Hamps Bio LimitedBSE: 544312 | $2.30M | Rs25.50 | +0.24% |
| Cannabis Strategic VenturesOTCPK: NUGS | $1.97M | $0.00 | -30.99% |
| City View Green Holdings Inc.CNSX: CVGR | $1.90M | CA$0.04 | -12.50% |
| Colinz Laboratories LimitedBSE: 531210 | $1.90M | Rs73.03 | -0.64% |
| Kanabo Group PlcLSE: KNB | $1.86M | £— | — |
Figures last refreshed Oct 11, 2026.